Zynerba Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ZYNE Zynerba Pharmaceuticals Inc
PDO PIMCO Dynamic Income Opportunities Fund
BOCT Innovator U.S. Equity Buffer ETF™ October
BAC Bank of America Corp
YARIY Yara International ASA
XOM Exxon Mobil Corp
XLF Financial Select Sector SPDR® Fund
XFLT XAI Octagon Floating Rate & Alternative Income Term Trust
WPC WP Carey Inc
WMT WALMART STORES INC
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Zynerba Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. The Company is engaged in improving the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome (FXS), and chromosome 22q11.2 deletion syndrome (22q). It is focused on using cannabinoids for treating behavioral symptoms of FXS and 22q. It is developing Zygel (ZYN002), a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol (THC). It uses a patent protected formulation containing ethanol and propylene glycol as solubilizing agents and Transcutol HP as a permeation enhancer. Zygel is an investigational drug product in development for the potential treatment of behavioral symptoms associated with FXS, 22q, and autism spectrum disorder (ASD).

Closing Price
$1.26
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
658,616

10-day average volume:
1,304,867
658,616

Tesla and Nio shares rise as EV makers get a broad lift after UAW calls strike

9:26 am ET September 15, 2023 (MarketWatch)
Print

By Tomi Kilgore

Tesla is seen as a potential beneficiary of labor woes at the Big Three legacy automakers, whose workers are already paid about 38% more than Tesla's

Shares of electric-vehicle makers traded broadly higher Friday following the decision by the United Auto Workers union to strike at plants of the Big Three legacy automakers.

Tesla Inc.'s stock (TSLA) rose 0.5% toward a two-month high in premarket trading, with the EV market leader seen as a key beneficiary of the labor troubles faced by General Motors Co. (GM), Ford Motor Co. (F) and Chrysler parent Stellantis N.V. (STLAM.MI).

Meanwhile, GM shares slipped 0.2%, Ford's stock lost 1.3% and Stellantis shares tacked on 0.5%.

The strike comes as the three automakers have been making a big push into the EV market, efforts that could be weakened by the higher costs and production disruptions resulting from a prolonged strike. The workers at the three companies already get paid about 38% more than Tesla's nonunion workforce.

Read: UAW strike: 12,700 Ford, GM and Stellantis auto workers walk off the job.

"If a strike is lengthy (4 weeks+) then ultimately production and the EV roadmap could be pushed out into 2024, and delays would be on the horizon at this crucial period [of EV execution] for GM, Ford and Stellantis," Wedbush analyst Dan Ives wrote in a note to clients.

Tesla is not the only company that could benefit from the UAW strike. The Global X Autonomous & Electric Vehicles exchange-traded fund DRIV rose 0.4% ahead of the market open, while futures for the S&P 500 index SPX slipped 0.1%.

Among other U.S.-based EV makers, shares of Nikola Corp. (NKLA) shot up 14.4%, shares of Rivian Automotive Inc. (RIVN) gained 0.5%, shares of Workhorse Group Inc. (WKHS) added 0.7%, shares of Fisker Inc. (FSR) were up 0.5% and shares of Mullen Automotive Inc. (MULN) advanced 7.0%.

Also read:Nikola stock soars, as CEO sees first hydrogen fuel cell trucks delivered by month end.

EV makers based in China were also getting a boost. Nio Inc.'s stock (NIO) climbed 1.7%, XPeng Inc. shares (XPEV) rose 1.3% and shares of Li Auto Inc. (LI) edged up 0.2%.

-Tomi Kilgore

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

	

(END) Dow Jones Newswires

September 15, 2023 09:26 ET (13:26 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.